the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Perlis Menteri Besar's son charged with submitting false claim for RM19,505

KANGAR: The son of the Perlis Menteri Besar pleaded not guilty in the Sessions Court here today to a charge of submitting a false claim amounting to RM19,505.10.

Mohd Syafeeq Mohd Shukri, 35, made the plea after the charge was read out to him before Judge Norsalha Hamzah.

He was charged with submitting a document, “Pesanan Kerajaan (Bekalan/Perkhidmatan) Kerajaan Negeri Perlis”, containing a false claim to Nurul Nabilah Mohd Sukri, an Administrative Assistant at the District Administration Division, Perlis State Secretary’s Office, on Feb 19 this year with an intent to deceive the principal.

Mohd Syafeeq is alleged to have reason to believe that the document, for a claim amounting to RM19,505.10, dated Feb 14, 2024, and in the name of Mohd Farid Abdul Hamid contained false details of the services provided for the Raja of Perlis Tuanku Syed Sirajuddin Jamalullail at the Tuanku Fauziah Hospital here.

The charge is framed under Section 18 of the Malaysian Anti-Corruption Commission (MACC) Act 2009 (Act 694), punished under Section 24(2) of the same law, which provides imprisonment for up to 20 years and a fine of not less than five times the amount or value of the bribe or RM10,000, whichever is higher upon conviction.

The court allowed Mohd Syafeeq bail at RM20,000 with one surety. He is also ordered to report himself at the nearest MACC Office once a month and surrender his passport to the court.

The court set June 28 for mention for the submission of documents.

MACC Deputy Public Prosecutor Rehab Abdul Shukur appeared for the prosecution, while lawyer Mohd Fadhly Yaacob represented Mohd Syafeeq.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings